Based on the findings of the Pharma & Hospital Report analysing the Romanian pharma market, Cegedim Customer Information estimates that the volume of medicines dispensed to patients in Romania totaled 710.8 million units in the last 12 months ended September 2025, 0.3% more than the dispensed volumes in the reference period (October 2023 – September 2024).
The total number of treatment days increased by 2.9%, driven by a 2.8% increase in retail, while the number of hospital treatment days increased by 5.2%.
During the same period, the value of medicines dispensed to patients in Romania increased by 11.9%, reaching RON 36.9 billion (EUR 7.37 billion) at the wholesale price level. Isolating the impact of the CVR and CV programs, the value of prescription medicines in retail pharmacies increased by 11.7% compared to the reference period, amounting to RON 19.11 billion (EUR 3.81 billion).
Pharma market evolution in Volume
In the third quarter of 2025, the total volume of medicines dispensed to patients reached 166.1 million units, marking a 2.2% decrease compared to the same quarter in 2024 (like-for-like market definition). This negative growth was mainly driven by a -2.1% fall in the retail channel, while hospital dispensations decreased by 5.1%. Analyzing the segments, prescription medications in pharmacies slightly decreased by 0.7%, whereas over-the-counter (OTC) products, which include both OTC drugs and nutritional supplements, fell by 4.4%.
From October 2024 to September 2025, the total volume of drugs dispensed to Romanian patients amounted to 710.8 million units, 0.3% more than the dispensing volume in the reference period (October 2023 – September 2024). Prescription-based medicines (Rx) from pharmacies increased to 418.7 million units (+0.9%), while OTC products in pharmacies totaled 261.2 million units, a small decrease of 0.8% from the reference period. In contrast, the hospital segment slightly advanced by 1.3%, accounting for 30.9 million units.
Pharma market evolution in Value
The total value of medicines dispensed to patients in the third quarter of 2025 reached RON 9.2 billion, 9.4% up compared to the same period last year. This growth was driven by an 8.7% increase in the retail sector and a 12.9% increase in hospital dispensations. Within the retail channel, the value of prescription (Rx) medicines rose by 10.5%, while over-the-counter (OTC) products increased by 3.6%.
The Rx medicines in retail, other than those assigned to cot-volume or cost-volume-result contracts, advanced by 10.6% compared to the third quarter of 2024.
From October 2024 to September 2025, the total market value reached RON 36.9 billion, reflecting a 11.9% increase compared to the reference period (October 2023 – September 2024). Prescription-based medicines (Rx) from pharmacies generated RON 22.6 billion, marking a 12.2% rise, while OTC products totaled RON 8.4 billion, which represents a 7.6% increase. The hospital segment contributed RON 5.9 billion, demonstrating a significant growth of 17.6%.
When isolating the substantial effects of the CVR and CV programs, which amounted to RON 3.5 billion, the value of prescription medicines in retail pharmacies increased by 11.7% from the reference period, reaching RON 19.11 billion (EUR 3.81 billion).
Main players in the Romanian pharmaceutical market in 2025
In the third quarter of 2025, the ranking of the top three corporations by volume remained unchanged. Sun Pharma (including Terapia) maintained its lead with 17.2 million units, followed by Zentiva (including Labormed and Alvogen) with 15.3 million units, and Servier (including Egis) with 11.0 million units.
During the same period , the top three hierarchy by value by value hasn’t changed vs the previous quarter. AstraZeneca maintained the leading position with RON 504.3 million, followed by Sun Pharma (including Terapia) with RON 411.8 million, and Zentiva (including Labormed and Alvogen) with RON 381.5 million.
To consult the complete information on the Romanian pharmaceutical market evolution in the third quarter of 2025 as well as the top players on this market during the same period, access directly our press release.
We also invite you to consult an executive summary of the study for the mentioned period, with graphical representations of the data presented in our article.
Pharma & Hospital Report, a reference study in the analysis of the pharmaceutical market in Romania, has been carried out since 1996.
